MammaPrint predicts chemotherapy benefit in HR+HER2 early breast cancer patients, observational FLEX study finds

ACOG says it will no longer accept federal funding

The American College of Obstetrics and Gynecology said it will no longer be accepting federal funding.

August 08, 2025

Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program

Antonio WolffMikala EgebladAntonio C. Wolff and Mikala Egeblad were named co-directors of the Breast and Gynecologic Cancer Program at Johns Hopkins Kimmel Cancer Center.

August 08, 2025

Vol.51 No.31

In Brief

Jaime LaMontagne named chief marketing officer of Astrin Biosciences

Jaime LaMontagne was appointed chief marketing officer of Astrin Biosciences.

August 08, 2025

Vol.51 No.31

Clinical Roundup

Respiratory viruses can wake up breast cancer cells in lungs, preclinical study shows

Common respiratory infections, including COVID-19 and influenza, can awaken dormant breast cancer cells that have spread to the lungs, setting the stage for new metastatic tumors, according to a preclinical study by researchers at the University of Colorado Anschutz Medical Campus, Montefiore Einstein Comprehensive Cancer Center, and Utrecht University.

August 01, 2025

Vol.51 No.30

Clinical Roundup

Tagrisso + chemo improve OS in EGFR-mutated advanced lung cancer, phase III trial shows

Tagrisso (osimertinib) plus chemotherapy delivers a statistically significant and clinically meaningful survival benefit compared to Tagrisso monotherapy in the first-line treatment of patients with locally advanced or metastatic epidermal growth factor receptor-mutated non-small cell lung cancer, according to results from the final overall survival analysis of the FLAURA2 phase III trial.

July 25, 2025

Vol.51 No.29

Clinical Roundup

ChristianaCare research reveals drivers behind advanced breast cancer in hotspots

Reduced screening rates and a higher prevalence of triple-negative breast cancer are driving elevated rates of advanced breast cancer in a geographic hotspot in Wilmington, Delaware, according to findings by researchers at ChristianaCare’s Cawley Center for Translational Cancer Research at the Helen F. Graham Cancer Center & Research Institute.

July 25, 2025

Vol.51 No.29

MammaPrint predicts chemotherapy benefit in HR+HER2 early breast cancer patients, observational FLEX study finds

YOU MAY BE INTERESTED IN

ACOG says it will no longer accept federal funding

Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program

Jaime LaMontagne named chief marketing officer of Astrin Biosciences

Respiratory viruses can wake up breast cancer cells in lungs, preclinical study shows

Tagrisso + chemo improve OS in EGFR-mutated advanced lung cancer, phase III trial shows

ChristianaCare research reveals drivers behind advanced breast cancer in hotspots

Renew today!

Subscriber content

Never miss an issue!

Login